Monthly information on share capital and company voting rights

Cellectis (CLLS) reported its monthly share capital and voting rights as of August 31, 2026, in line with Article 223-16 of the French financial markets authority.

Rhea-AI Summary

Cellectis (CLLS) reported its monthly share capital and voting rights as of August 31, 2026, in line with Article 223-16 of the French financial markets authority.

The company had 100,718,974 shares outstanding and a total of 105,568,956 voting rights on that date. The shares are listed on Euronext Growth under ISIN code FR0010425595.

Market Context

The September 1 conference announcement established a recent neutral-news comparator for Cellectis. ...

Analysis

The September 1 conference announcement established a recent neutral-news comparator for Cellectis. This disclosure adds monthly ownership data, while the effective F-3 shelf through July 2, 2028 remains a relevant financing risk to monitor.

Key Figures

Disclosure date: 08/31/2026 Shares outstanding: 100,718,974 shares Total voting rights: 105,568,956 voting rights

3 metrics

Disclosure date 08/31/2026 Share-capital and voting-rights table

Shares outstanding 100,718,974 shares As of 08/31/2026

Total voting rights 105,568,956 voting rights As of 08/31/2026

Historical Context

5 past events · Latest: Sep 01 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Sep 01	Investor conference notice	Neutral	-1.5%	Announced participation in healthcare investor conferences from September through November 2026.
Aug 06	Second-quarter earnings	Positive	+5.4%	Reported clinical updates, financial results and cash resources for first-half 2026.
Aug 05	Share-capital disclosure	Neutral	-3.6%	Reported July 31 shares outstanding and total voting rights.
Jul 30	Earnings date notice	Neutral	-3.5%	Scheduled second-quarter 2026 results for August 6 after the U.S. market close.
Jul 02	Share-capital disclosure	Neutral	-0.3%	Reported June 30 shares outstanding and total voting rights.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The two prior monthly share-capital disclosures were followed by negative 24-hour reactions, while the August 6 earnings report was followed by a positive reaction.

Key Terms

article 223-16, isin code

2 terms

article 223-16 regulatory

"Article 223-16 of General Regulation of the French financial markets authority"

Article 223-16 is a rule that requires certain financial firms, like banks and investment companies, to report their large or suspicious transactions to authorities. This helps prevent illegal activities such as money laundering or fraud, making the financial system safer and more transparent.

isin code financial

"Listing market: Euronext Growth ISIN code: FR0010425595"

An ISIN code is a unique identifier for a specific financial asset, like a stock or bond, similar to a product's barcode. It helps investors, traders, and banks quickly and accurately find and track that asset across different markets worldwide. This makes buying, selling, and managing investments more organized and reliable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Sept. 03, 2026 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
08/31/2026	100,718,974	105,568,956

For further information on Cellectis, please contact:         

Media contacts:              
Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com  
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93      
    
Investor Relations contact:           
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com   

Attachment

• Voting_Rights_PR_August_2026_EN

FAQ

How many shares does Cellectis (CLLS) have as of August 31, 2026?

As of August 31, 2026, Cellectis had a total of 100,718,974 shares in its share capital, as reported in its monthly disclosure under Article 223-16.

What is the total number of voting rights for Cellectis (CLLS) as of August 31, 2026?

Cellectis reported a total of 105,568,956 voting rights as of August 31, 2026. This figure reflects all voting rights attached to the company’s outstanding shares.

On which market and under which ISIN is Cellectis (CLLS) listed?

Cellectis shares are listed on Euronext Growth with ISIN code FR0010425595. The company publishes monthly information on its share capital and voting rights in line with French market regulations.

Why did Cellectis (CLLS) publish monthly information on share capital and voting rights?

Cellectis published the data to comply with Article 223-16 of the General Regulation of the French financial markets authority, which requires monthly disclosure of total shares in the capital and total voting rights.